Overview

OLE Study to Evaluate Safety / Efficacy of ZD4522

Status:
Completed
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the long term safety of Crestor.
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Rosuvastatin Calcium